Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoprotein(a) mRNA is the messenger RNA transcript that encodes apolipoprotein(a), a key protein component of lipoprotein(a) [Lp(a)]. Lp(a) is a complex plasma lipoprotein particle consisting of an LDL-like core covalently linked to apolipoprotein(a). Targeting this mRNA with antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) represents a therapeutic strategy to reduce Lp(a) levels and associated cardiovascular risk.
mRNA degradation or translational arrest via ASO or siRNA binding
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein(a) mRNA (LPA mRNA).